Gene
What are genes?
Genes are sections of DNA in your cells that are passed down (inherited) from your parents. You inherit two copies of each gene, one from each parent. Genes carry information that controls what you look like and how your body works.
There are about 20,000 genes that provide instructions for making proteins, which your body needs to work correctly.
Some genes don't make proteins themselves but instead help control how other genes work. They act like switches, turning other genes on or off. This means they help decide when, where, and how much of a protein is made in your body.
What happens when genes change?Changes in your genes are also called gene variants or mutations. These changes can be inherited, occur as you age, or result from environmental factors such as chemicals or radiation. Often, these changes have no effect, but sometimes, even a small change in the DNA can alter the instructions for making proteins. If genes don't make the right proteins, or don't make them correctly, this can cause a genetic disorder.
What is gene therapy?Gene therapy uses genes to treat or prevent disease by correcting genetic problems. It works by changing your genetic material, rather than relying on traditional treatments like medicine or surgery.
New genetic material can be delivered into cells in two main ways:
- ex-vivo treatment. Cells are removed from your body, modified by adding genetic material, and then placed back into your body.
- in-vivo treatment. Genetic material is delivered directly into your body, often through an injection.
A common form of gene therapy involves inserting a normal gene to replace an abnormal gene. Other approaches include:
- Repairing an abnormal gene
- Altering the degree to which a gene is turned on or off
Newer techniques offer different ways to correct genetic problems:
- Genome editing (also called gene editing). Instead of adding new genetic material into cells, this approach changes the DNA that's already in your cells. A well-known example is CRISPR-Cas9. This promising technique is still being studied and may soon be used to treat genetic disorders.
- Cell-based gene therapy combines gene therapy and cell therapy. An example of this would be CAR T cell therapy. Cells, which are often immune system cells, are genetically altered to help treat a disease and then introduced into the body.
Gene therapies are currently only approved to treat a small number of diseases, such as:
- Leber congenital amaurosis, an inherited eye disorder.
- Spinal muscular atrophy, a genetic muscle disorder.
While gene therapy holds great promise, it comes with risks and challenges. Studies are still ongoing to ensure these treatments are safe and effective. Some challenges include:
- Immune system reactions. Your body may see the new material as a threat and react to it.
- Unintended effects. Changes to DNA could affect other genes in harmful ways.
- High costs. Gene therapies are often expensive and are not widely accessible.
Gene FDA Approved Drugs
- Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes.
- Treatment of a neurodegenerative disease or a symptom thereof.
- Replacement therapy for oral carbamazepine in adults with generalized tonic-clonic seizures.
- Replacement therapy for oral carbamazepine in adults with mixed seizure patterns that include partial seizures with complex symptomatology, generalized tonic-clonic seizures, or other partial or generalized seizures.
- Replacement therapy for oral carbamazepine in adults with partial seizures with complex symptomatology.
- Treatment of depression and generalized anxiety disorder.
- Treatment of social anxiety disorder.
- (i)treatment of duchenne muscular dystrophy; (ii)restoring/increasing functional dystrophin protein; or (iii) inducing skipping; each of (i)-(iii) in patients having a confirmed mutation of the dmd gene that is amenable to exon 51 skipping.
- Restoring an mrna reading frame to induce dystrophin protein production in patients having a mutation of the dmd gene that is amenable to exon 51 skipping.
- Treatment of duchenne muscular dystrophy in patients having a mutation of the dmd gene that is amenable to exon 51 skipping.
Bio-pharm IncMar 27, 2015
Fresenius KabiJan 25, 2012
Hi Tech PharmaJul 3, 1995
Morton GroveNov 14, 1996
Pharm AssocJul 30, 1996
Vintage PharmsJul 26, 2001
VistapharmSep 30, 1992
West-ward Pharms IntMay 29, 1992
Cumberland PharmsDec 10, 1997
- Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures.
- Method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in a once-a-day amoxicillin product.
- Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes.
- Prophylaxis of organ rejection in patients receiving allogeneic renal transplants.
- Treatment of a neurodegenerative disease or a symptom thereof.
- Treatment of hallucinations and delusions associated with parkinson's disease psychosis.
- Treatment of parkinson's disease psychosis.
- Treatment of psychosis or a symptom thereof.
- Treatment of psychosis.
- Method of treating a patient having cystic fibrosis using ivacaftor and lumacaftor.
- Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using a dosage unit as defined in claim 1 of u.s. patent no. 9,192,606.
- Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using ivacaftor and form i lumacaftor.
- Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using ivacaftor and lumacaftor.
- Method of treating cystic fibrosis in a patient, the patient having the f508del mutation in cftr, using the dosage unit of claim 1 of u.s. patent no. 8,716,338.
- Method of treating cystic fibrosis in patients who are homozygous for the f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
- Method of treating cystic fibrosis in patients who have the f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene..
- Method of treating cystic fibrosis using n-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1h-quinoline-3-carboxamide and 3-(6-(1-2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid.
- Method of treating cystic fibrosis.
- Treatment of acute promyelocytic leukemia (apl) in patients whose apl is characterized by the presence of the (15;17) translocation or pml/rar-alpha gene expression.
- Treatment of acute promyelocytic leukemia (apl).
- Treatment of acute promyelogenous leukemia (apl).
- A method of generating an injectable foam of controlled density and bubble size.
- A method of intravenous injection using ultrasound guidance, administered via a single cannula into the lumen of the target incompetent trunk veins or by direct injection into varicosities.
- A method of using a sclerosing agent for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous (gsv) system above and below the knee.
Home Remedies for Gene
   The only real "cure" is taking Lamisil (terbinafine hydrochloride) tablets prescribed by a doctor. The longer durations (at weaker doses) allow the nail to grow out. However, this medication can damage your liver. Once the initial infection is under control, brush Vicks Vaporub (or generic) under and around the nail with a toothbrush twice a day to reduce the chance of coming back.Sleslie | July 26th, 2021
